Autoimmune Diseases  >>  Remozen (remogliflozin etabonate)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Remozen (remogliflozin etabonate) / Islet Sci
NCT00575159: A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus

Completed
2
10
US
GSK189075, placebo
GlaxoSmithKline
Diabetes Mellitus, Type 1
12/08
12/08

Download Options